Seroprevalence of Kaposi's sarcoma‐associated herpesvirus among HIV‐infected Uygurs in Xinjiang, China. Issue 9 (11th April 2017)

• Record Type: Journal Article
• Authors: Liu, Zhenqiu; Fang, Qiwen; Zhou, Sujuan; Minhas, Veenu; Wood, Charles; He, Na; Zhang, Tiejun
• Is Part Of: Journal of medical virology. Volume 89:Issue 9(2017)
• Page Start: 1629
• Page End: 1635
• Publication Date: 2017-04-11
• Subjects: China -- HIV -- KSHV; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.24804
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract : Kaposi's sarcoma‐associated herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma (KS), which primarily affects human immunodeficiency virus (HIV)‐infected adults with advanced immunodeficiency. Xinjiang province in China is an endemic area for Kaposi's sarcoma (KS), however, currently, only limited data for KSHV infection among HIV‐infected individuals living in this endemic area is available. A cross‐sectional study of 86 HIV positive participants was conducted in Xinjiang, China from 2014 through 2015. Plasma samples were collected and screened for KSHV and HIV infection. HIV pol gene and KSHV ORF‐K1 gene were amplified and sequenced, genotypes were determined by phylogenetic analysis. Over all, prevalence was 48.9% (42/86; 95%CI 38.4‐59.3%) for KSHV. Only CRF07_BC subtype has been identified among all these HIV positive individuals, while the subtype A and C of KSHV were detected in the participants. Meanwhile, we found that those with high CD4 counts (>500) showed a lower anti‐KSHV titer, compared with other groups. Our study indicated a high prevalence of KSHV among HIV positive individuals in Xinjiang, China. Thus, management of HIV/AIDS patients should include KSHV screen and should consider the risk of KSHV‐associated malignancies.